Movano Health Submits Exemplary Sp02 Clinical Trial Results in Key Step Towards FDA 510(k) Clearance Decision [Yahoo! Finance]
Movano Inc. (MOVE)
Company Research
Source: Yahoo! Finance
PLEASANTON, Calif. May 9, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced that it successfully submitted updated pivotal clinical trial results as well as proof of enhanced medical device usability on April 22, 2024 to the U.S. Food and Drug Administration (FDA) as part of its 510(k) filing for the Company's first commercial medical device, the Evie Med Ring pulse oximeter. An FDA clearance would bring Movano Health a significant step closer in its pursuit to disrupt the wearables industry while unlocking significant partnership opportunities. The Company continues to expect a decision regarding its 510(k) clearance in July 2024. "From the outset, our vision has been to develop a wearable that fits with any lifestyle and is cleared by the FDA as a medical device," said John Mastrototaro , CEO of Movano Health. "The exemplary results of our latest study are a critical component of our FDA filing and lay the groundwork to fulfilling all aspects of that goal." In January
Show less
Read more
Impact Snapshot
Event Time:
MOVE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MOVE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MOVE alerts
High impacting Movano Inc. news events
Weekly update
A roundup of the hottest topics
MOVE
News
- Evie, Movano Health's Smart Ring for Women, is Back In Stock with Key UpgradesPR Newswire
- Movano Inc. (NASDAQ: MOVE) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $2.00 price target on the stock.MarketBeat
- Movano Health Advances to Final Phase of FDA Review Process for EvieMED RingPR Newswire
- Movano Inc. (MOVE) Q2 2024 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Movano Health Reports Q2 2024 Financial Results and Provides Business UpdatePR Newswire
MOVE
Sec Filings
- 9/16/24 - Form 424B5
- 8/16/24 - Form S-8
- 8/14/24 - Form 8-K
- MOVE's page on the SEC website